ReviewNature2019
Immunization: vital progress, unfinished agenda.
Review in Nature, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 119 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
119 citing papers in PubMed, 4 syntheses or guidelines pooled it.
- Willingness to pay for vaccines in China: A systematic review and single-arm Bayesian meta-analysis.Human vaccines & immunotherapeutics · 2025Pooled it
- Pooled it
- Acceptability of mobile-phone reminders for routine childhood vaccination appointments in Nigeria - a systematic review and meta-analysis.BMC health services research · 2021Pooled it
- Improving vaccination uptake among adolescents.The Cochrane database of systematic reviews · 2020Pooled it
- Consequences of post-discharge hospitalisation on the growth of young Bangladeshi children hospitalised with diarrhoea: a secondary case-control analysis of Antibiotics for Children with Diarrhea (ABCD) trial.Journal of global health · 2025Trial
- Effect of tailored information of vaccination schedule on vaccine uptake in northern Nigeria.Human vaccines & immunotherapeutics · 2021Trial
- Exploring the impact of reimbursement ratios on willingness to vaccinate: A mixed-effects modeling approach using panel data.Human vaccines & immunotherapeutics · 2026Article
- CRISPR-Cas and Infectious Diseases: A Decade of Translational Advances in Molecular Biotechnology.Biochemical genetics · 2026Review
- Variability in the TLR3 type I interferon pathway is predictive of RNA vaccine responses.Science advances · 2026Article
- Global Health Reform through a Regional Lens: The Middle East and Central Asia Perspective.Journal of epidemiology and global health · 2026Article
- Tracking Canada's 2015 vaccine research and development priorities: Where are we a decade later?Canada communicable disease report = Releve des maladies transmissibles au Canada · 2026Article
- Innate Immunity Trained in the Protective Response of Vaccine Candidates Against Intracellular Pathogens.Vaccines · 2026Article
- Economic evaluation of national immunization program vaccines in China: a systematic review.Health economics review · 2026Review
- Article
- Concerns and challenges in clinics-guided nanovaccines design and applications.Acta pharmaceutica Sinica. B · 2026Review
- Childhood vaccination coverage and socioeconomic inequalities in the Northern region of Brazil.Revista brasileira de epidemiologia = Brazilian journal of epidemiology · 2026Article
- Article
- Current status of vaccine clinical trials registered on China's Drug Trial Registration and information disclosure platform, 2013-2024.Frontiers in public health · 2026Article
- A single-dose mRNA vaccine induces potent and long-lasting humoral and cellular immunity against the varicella-zoster virus in a murine model.Frontiers in immunology · 2026Article
- Rethinking global health financing: from philanthropy to public good.Global health research and policy · 2025Article
59 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Vaccination against infectious diseases has changed the future of the human species, saving millions of lives every year, both children and adults, and providing major benefits to society as a whole. Here we show, however, that national and sub-national coverage of vaccination varies greatly and major unmet needs persist. Although scientific progress opens exciting perspectives in terms of new vaccines, the pathway from discovery to sustainable implementation can be long and difficult, from the financing, development and licensing to programme implementation and public acceptance. Immunization is one of the best investments in health and should remain a priority for research, industry, public health and society.
Indexed as
Identifiers
31695203What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.